HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region

Immunology Letters

Volumn 108, Issue 2, 2007, Pages 143-150

  Han, Songyan ^a   Lu, Jun ^a   Zhang, Yu ^a   Cheng, Cao ^a   Li, Lin ^a   Han, Liping ^a   Huang, Baiqu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

HDAC inhibitors; HDACs; Histone hyperacetylation; IL 5

Indexed keywords

BUTYRIC ACID; HISTONE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; INTERLEUKIN 5; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR YY1; TRICHOSTATIN A;

ACETYLATION; ALLERGIC DISEASE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EOSINOPHIL; GENE CONTROL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

ACETYLATION; BUTYRIC ACID; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; ENZYME INHIBITORS; GENE EXPRESSION; GENES, REPORTER; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; INTERLEUKIN-5; IONOMYCIN; JURKAT CELLS; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 33846695671     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.12.001     Document Type: Article

References (33)

1. Workman J.L., and Buchman A.R. Multiple functions of nucleosomes and regulatory factors in transcription. Trends Biochem Sci 18 (1993) 90-95
2. Beato M., and Eisfeld K. Transcription factor access to chromatin. Nucleic Acids Res 25 (1997) 3559-3563
3. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389 (1997) 349-352
4. Hassig C.A., and Schreiber S.L. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1 (1997) 300-308
5. Van Lint C., Emiliani S., and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5 (1996) 245-253
6. Yoshida M., and Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 177 (1988) 122-131
7. Yoshida M., Horinouchi S., and Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17 (1995) 423-430
8. Chang S.T., and Yung B.Y. Potentiation of sodium butyrate-induced apoptosis by vanadate in human promyelocytic leukemia cell line HL-60. Biochem Biophys Res Commun 221 (1996) 594-601
9. Rosato R.R., and Grant S. Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther 2 (2003) 30-37
10. Venarske D., and deShazo R.D. Molecular mechanisms of allergic disease. South Med J 96 (2003) 1049-1054
11. Martin L.B., Kita H., Leiferman K.M., and Gleich G.J. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 109 (1996) 207-215
12. Crabtree G.R. Contingent genetic regulatory events in T lymphocyte activation. Science 243 (1989) 355-361
13. Avni O., Lee D., Macian F., Szabo S.J., Glimcher L.H., and Rao A. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol 3 (2002) 643-651
14. Yamashita M., Ukai-Tadenuma M., Kimura M., Omori M., Inami M., Taniguchi M., et al. Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J Biol Chem 277 (2002) 42399-42408
15. Stranick K.S., Zambas D.N., Uss A.S., Egan R.W., Billah M.M., and Umland S.P. Identification of transcription factor binding sites important in the regulation of the human interleukin-5 gene. J Biol Chem 272 (1997) 16453-16465
16. Schwenger G.T., Mordvinov V.A., Karlen S., D'Ercole M., and Sanderson C.J. Identification of two novel palindromic regulatory elements in the murine interleukin-5 promoter. Mol Immunol 35 (1998) 149-158
17. Li-Weber M., Giaisi M., and Krammer P.H. Roles of CCAAT/enhancer-binding protein in transcriptional regulation of the human IL-5 gene. Eur J Immunol 31 (2001) 3694-3703
18. Schwenger G.T., Fournier R., Kok C.C., Mordvinov V.A., Yeoman D., and Sanderson C.J. GATA-3 has dual regulatory functions in human interleukin-5 transcription. J Biol Chem 276 (2001) 48502-48509
19. De Boer M.L., Mordvinov V.A., Thomas M.A., and Sanderson C.J. Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells. Int J Biochem Cell Biol 31 (1999) 1221-1236
20. Schwenger G.T., Fournier R., Hall L.M., Sanderson C.J., and Mordvinov V.A. Nuclear factor of activated T cells and YY1 combine to repress IL-5 expression in a human T-cell line. J Allergy Clin Immunol 104 (1999) 820-827
21. Mordvinov V.A., Schwenger G.T., Fournier R., De Boer M.L., Peroni S.E., Singh A.D., et al. Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells. J Allergy Clin Immunol 103 (1999) 1125-1135
22. Schwenger G.T., Kok C.C., Arthaningtyas E., Thomas M.A., Sanderson C.J., and Mordvinov V.A. Specific activation of human interleukin-5 depends on de novo synthesis of an AP-1 complex. J Biol Chem 277 (2002) 47022-47027
23. Blumenthal S.G., Aichele G., Wirth T., Czemilofsky A.P., Nordheim A., and Dittmer J. Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. J Biol Chem 274 (1999) 12910-12916
24. Fishkoff S.A., and Condon M.E. Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions. Cancer Res 45 (1985) 2065-2069
25. Ishihara K., Hong J., Zee O., and Ohuchi K. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. Br J Pharmacol 142 (2004) 1020-1030
26. Jee Y.K., Gilmour J., Kelly A., Bowen H., Richards D., Soh C., et al. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J Biol Chem 280 (2005) 23243-23250
27. Choi J.H., Oh S.W., Kang M.S., Kwon H.J., Oh G.T., and Kim D.Y. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35 (2005) 89-96
28. Kovacs K.A., Steinmann M., Magistretti P.J., Halfon O., and Cardinaux J.R. CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. J Biol Chem 278 (2003) 36959-36965
29. Garcia-Rodriguez C., and Rao A. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J Exp Med 187 (1998) 2031-2036
30. Yamagata T., Mitani K., Oda H., Suzuki T., Honda H., Asai T., et al. Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs. EMBO J 19 (2000) 4676-4687
31. Yang W.M., Inouye C., Zeng Y., Bearss D., and Seto E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 93 (1996) 12845-12850
32. Liu C., Lu J., Tan J., Li L., and Huang B. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1. Cytokine 27 (2004) 93-100
33. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., and Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 (1989) 51-59